Head-to-Head

Iovance Biotherapeutics, Inc. Common Stock vs. Krystal Biotech, Inc. Common Stock

IOVA

Iovance Biotherapeutics, Inc. Common Stock

$10.25 +2.30%

VS KRYS

Krystal Biotech, Inc. Common Stock

$336.67 -0.61%

Krystal Biotech, Inc. Common Stock (KRYS) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

IOVAKRYS
Market Cap $4.64 billion $9.97 billion
Revenue (TTM) — $440.48 million
Net Income (TTM) — $241.47 million

KRYS leads on 1 of 1 size & scale factors.

Valuation

IOVAKRYS
P/E Ratio — 42.19
Price / Book — 7.33
Price / Sales — 22.62

IOVA and KRYS split the valuation factors evenly.

Profitability

IOVAKRYS
Net Margin — 54.82%
Return on Equity — 17.77%

IOVA and KRYS split the profitability factors evenly.

Risk & Sentiment

IOVAKRYS
Short Interest 0.81% 0.11%

KRYS leads on 1 of 1 risk & sentiment factors.

Dig deeper: IOVA overview, IOVA financials, KRYS overview, KRYS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.